Storm Therapeutics
PrivateLast Round
Series C
Apr 16, 2026
Est. Valuation
$50.5M
Total Funding Raised
$120.99M
Company Overview
STORM Therapeutics is a biotechnology company focused on developing small molecule therapies that target RNA modification enzymes for the treatment of cancer and other immune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Storm Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Storm Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 16, 2026 | ||||
| Series B | Dec 14, 2022 | ||||
| Grant | May 3, 2022 | ||||
| Series A Extension | May 20, 2019 | ||||
| Grant | Sep 3, 2018 | ||||
Series A | Jun 28, 2016 |
Storm Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| UK Research and Innovation | Grant |
| IP Group | Series B, Series C |
| Seroba Life Sciences | Series B, Series A Extension |
| Taiho Ventures | Series A Extension, Series C, Series B |
| M Ventures | Series C |
| Merck KGaA | Series B, Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
$56M round completed.
- Feb 12, 2026
Collaborating with Sygnature Discovery on DHX9 inhibitor program.
Storm Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Storm Therapeutics's valuation, stock price, and market status.
